Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Cessation of drug use in chronic opiate abusers produces a severe withdrawal syndrome that is highly aversive, and avoidance of withdrawal or associated stimuli is a major factor contributing to opiate abuse. Increased noradrenaline in the brain has long been implicated in opiate withdrawal, but it has not been clear which noradrenergic systems are involved. Here we show that microinjection of beta-noradrenergic-receptor antagonists, or of an alpha2-receptor agonist, into the bed nucleus of the stria terminalis (BNST) in rats markedly attenuates opiate-withdrawal-induced conditioned place aversion. Immunohistochemical studies revealed that numerous BNST-projecting cells in the A1 and A2 noradrenergic cell groups of the caudal medulla were activated during withdrawal. Lesion of these ascending medullary projections also greatly reduced opiate-withdrawal-induced place aversion, whereas lesion of locus coeruleus noradrenergic projections had no effect on opiate-withdrawal behaviour. We conclude that noradrenergic inputs to the BNST from the caudal medulla are critically involved in the aversiveness of opiate withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By contrast, the stress-induced reinstatement of drug-related responding in animal models appears to depend on the activation of both CRF and norepinephrine in elements of the extended amygdala (ie, central nucleus of the amygdala and bed nucleus of the stria terminalis; tables 1, 2, circuits 16 and 17)22,33,53,96–98 and the ventral tegmental area (tables 1, 2, circuit 9).”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [22]
In the citing paper
“As tolerance and withdrawal develop, brain stress systems, such as CRF, norepinephrine, and dynorphin, are recruited in the extended amygdala and contribute to the development of negative emotional states in withdrawal and protracted abstinence (tables 1, 2, circuits 6–8).”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [22]
Citations
Cites
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,151
Paxinos, G. (1985) · Cited by 3,715
Clonidine blocks acute opiate-withdrawal symptoms
Gold, M., Redmond, D. E., & Kleber, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92823-4 · Cited by 710
Stinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317
Pothos, E., Rada, P., Mark, G. P., & Hoebel, B. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91724-f · Cited by 288 · cited 1×
“Increased noradrenaline during opiate withdrawal has also been linked to decreased dopamine in the NA”
BackgroundSchulteis, G., Markou, A., Gold, L. H., Stinus, L., & Koob, G. F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24024-1 · Cited by 285
The Lower Brainstem and Bodily Homeostasis
Loewy, A. D. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01234-x · Cited by 260
The Lower Brainstem and Bodily Homeostasis
Blessing, W. W. (1997) · Cited by 254
Tejani-Butt, S. M. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11249-4 · Cited by 239
Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
Harris, G. C., & Aston-Jones, G. (1994) · Nature · doi:10.1038/371155a0 · Cited by 214
Self-citation
Research works printed but not linked: 2
- Akaoka, H., Zhu, Y., Shipley, M. T. & Aston-Jones, G. Expression of fos protein in central catecholamine neurons during opiate withdrawal. Soc. Neurosci. Abstr. 18, 374 (1992).
- McKittrick, C. R., Delfs, J. M., Aston-Jones, G. & Abercrombie, E. D. Differential spontaneous and withdrawal-induced efflux of catecholamines in nucleus accumbens shell of morphine-treated rats. Soc. Neurosci. Abstr. 25, 948 (1999).
Cited by
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Neurobiology of addiction: a neurocircuitry analysis
Koob, G. F., & Volkow, N. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00104-8 · Cited by 3,698
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Synaptic plasticity and addiction
Kauer, J. A., & Malenka, R. C. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2234 · Cited by 1,397
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056
“…localized the effects of norepinephrine in driving opioid withdrawal showed that ventral noradrenergic bundle lesions attenuated opioid withdrawal (Delfs et al., 2000), but virtually complete lesions of the dorsal noradrenergic bundle from the locus coeruleus with the neurotoxin 6-hydroxydopamine…”
The Vertebrate mesolimbic reward system and social behavior network: A comparative synthesis
O'Connell, L. A., & Hofmann, H. A. (2011) · Journal of Comparative Neurology · doi:10.1002/cne.22735 · Cited by 1,023
“…mediating motivational behavior, much recent attention has been directed toward the BNST, as this region plays a role in the motivational aspects of drug abuse (Delfs et al., 2000) and can generate long-lasting excitatory effects on dopaminergic neurons in the VTA (Georges and Aston-Jones, 2001).”
BackgroundReward Processing by the Opioid System in the Brain
Le Merrer, J., Becker, J. A. J., Befort, K., & Kieffer, B. L. (2009) · Physiological Reviews · doi:10.1152/physrev.00005.2009 · Cited by 1,013
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Williams, J. T., Christie, M. J., & Manzoni, O. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.299 · Cited by 848
Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety
Walker, D. L., Toufexis, D. J., & Davis, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01282-2 · Cited by 838
Neurobiological mechanisms for opponent motivational processes in addiction
Koob, G. F., & Le Moal, M. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0094 · Cited by 702
Stress-induced relapse to heroin and cocaine seeking in rats: a review
Shaham, Y., Erb, S., & Stewart, J. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00024-2 · Cited by 700
Opioid receptors: Distinct roles in mood disorders
Lutz, P.-E., & Kieffer, B. L. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.002 · Cited by 542
Dong, H., Petrovich, G. D., Watts, A. G., & Swanson, L. W. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1079 · Cited by 521
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
“…with dependence or abuse potential, with a common response of elevated adrenocorticotropic hormone, corticosterone, and amygdala CRF during acute withdrawal (Rivier et al., 1984; Merlo-Pich et al., 1995; Koob et al., 1994; Rasmussen et al., 2000; Olive et al., 2002; Delfs et al., 2000; Koob, 2009).”
BackgroundCellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction
Christie, M. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.100 · Cited by 478
Neurobiology of opioid addiction: Opponent process, hyperkatifeia, and negative reinforcement
Koob, G. F. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.023 · Cited by 477
Role of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 476
Neurobiological substrates for the dark side of compulsivity in addiction
Koob, G. F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.043 · Cited by 458
The dark side of emotion: the addiction perspective
Koob, G. F. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.044 · Cited by 433
“…potential, with a common response of elevated adrenocorticotropic hormone, corticosterone, and amygdala CRF during acute withdrawal (Rivier et al., 1984; Merlo-Pich et al., 1995; Koob et al., 1994; Rasmussen et al., 2000; Olive et al., 2002; Delfs et al., 2000; Koob, 2009; Roberto et al., 2010).”
BackgroundHistorical review: molecular and cellular mechanisms of opiate and cocaine addiction
Nestler, E. J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.005 · Cited by 425
Koob, G. F. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_129 · Cited by 423
The neurobiology of addiction: a neuroadaptational view relevant for diagnosis
Koob, G. F. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01586.x · Cited by 397
Addiction is a Reward Deficit and Stress Surfeit Disorder
Koob, G. F. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00072 · Cited by 397
Keep off the grass? Cannabis, cognition and addiction
Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.28 · Cited by 389
Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction
Aston-Jones, G., Smith, R. J., Sartor, G. C., Moorman, D. E., Massi, L., Tahsili-Fahadan, P., & Richardson, K. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.106 · Cited by 389
Self-citationBrain stress systems in the amygdala and addiction
Koob, G. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.038 · Cited by 388
“, β1 antagonist and α2 agonist) blocked opioid withdrawal-induced place aversion (Delfs et al., 2000).”
BackgroundCommon cellular and molecular mechanisms in obesity and drug addiction
Kenny, P. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3105 · Cited by 382
The Role of Corticotropin-Releasing Factor in Drug Addiction
Sarnyai, Z., Shaham, Y., & Heinrichs, S. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01492-3 · Cited by 351
Redish, A. D., Jensen, S., Johnson, A., & Kurth-Nelson, Z. (2007) · Psychological Review · doi:10.1037/0033-295x.114.3.784 · Cited by 346
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
The human BNST: functional role in anxiety and addiction
Avery, S. N., Clauss, J. A., & Blackford, J. U. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.185 · Cited by 331
Walker, D. L., Miles, L. A., & Davis, M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.022 · Cited by 331
Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis
Becker, J. B., Perry, A. N., & Westenbroek, C. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-14 · Cited by 317
Addiction and Stress: An Allostatic View
Koob, G. F., & Schulkin, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.008 · Cited by 315
Neurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310
α1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates
Drouin, C., Darracq, L., Trovero, F., Blanc, G., Glowinski, J., Cotecchia, S., & Tassin, J.-P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02873.2002 · Cited by 296
The role of CRF and CRF-related peptides in the dark side of addiction
Koob, G. F. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.008 · Cited by 290
Goehler, L. E., Park, S. M., Opitz, N., Lyte, M., & Gaykema, R. P. A. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.08.009 · Cited by 287
“Clues to a mechanism, however, derive from studies investigating the neural basis of increased negative affect associated with opiate withdrawal (Delfs et al., 2000; Harris and Aston-Jones, 2007).”
BackgroundGeorges, F., & Aston-Jones, G. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05173.2002 · Cited by 286
Self-citationDrug addiction: Pathways to the disease and pathophysiological perspectives
Le Moal, M., & Koob, G. F. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.10.006 · Cited by 283
Neuroadaptive mechanisms of addiction: studies on the extended amygdala
Koob, G. F. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.005 · Cited by 278
Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework
Koob, G. F., & Colrain, I. M. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0446-0 · Cited by 276
Sex differences in the neurobiology of drug addiction
Bobzean, S. A. M., DeNobrega, A. K., & Perrotti, L. I. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.01.022 · Cited by 262
Cecchi, M., Khoshbouei, H., Javors, M., & Morilak, D. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00062-3 · Cited by 244
Olive, M. F., Koenig, H. N., Nannini, M. A., & Hodge, C. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00748-1 · Cited by 237
Martin, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00287.x · Cited by 237
Brain substrates for increased drug seeking during protracted withdrawal
Aston-Jones, G., & Harris, G. C. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.020 · Cited by 233
Self-citationWalker, D. L., & Davis, M. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0183-3 · Cited by 231
“Lesions of the ventral noradrenergic bundle, which interrupt the projection of these cell groups to the BNST, reduce opiate-withdrawal-induced place aversion, as do injections of b-adrenergic-receptor antagonists into the BNST itself, even though these same manipulations have little effect on the somatic symptoms of w…”
BackgroundNeurocircuitry of alcohol addiction
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-62619-6.00003-3 · Cited by 225
Locus Coeruleus, A5 and A7 Noradrenergic Cell Groups
Aston-Jones, G. (2004) · The Rat Nervous System · doi:10.1016/b978-012547638-6/50012-2 · Cited by 216
Self-citationkappa-Opioid receptor signaling and brain reward function
Bruijnzeel, A. W. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.09.008 · Cited by 214
Ferry, L., & Johnston, J. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10468.x · Cited by 209
The brainstem noradrenergic systems in stress, anxiety and depression
Itoi, K., & Sugimoto, N. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.01988.x · Cited by 207
Smith, R. J., & Aston-Jones, G. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0191-3 · Cited by 206
“3) (Aston-Jones et al. 1999; Delfs et al. 2000; Stornetta et al. 1993).”
BackgroundResultInfluentialSelf-citationDrug-Induced Conditioned Place Preference and Its Practical Use in Substance Use Disorder Research
McKendrick, G., & Graziane, N. M. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.582147 · Cited by 205
Rogers, J. L., Ghee, S., & See, R. E. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.012 · Cited by 204
Rinaman, L. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00556.2010 · Cited by 201
Cryan, J. F., Page, M. E., & Lucki, I. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01628-4 · Cited by 185
Geerling, J. C., & Loewy, A. D. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90399.2008 · Cited by 182
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 180
Frenois, F., Cador, M., Caillé, S., Stinus, L., & Le Moine, C. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02187.x · Cited by 179
Walters, C. L., & Blendy, J. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09438.2001 · Cited by 175
Tobacco addiction and the dysregulation of brain stress systems
Bruijnzeel, A. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.015 · Cited by 173
Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability
Fowler, C. D., & Kenny, P. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.008 · Cited by 169
Richard, J. E., Anderberg, R. H., Göteson, A., Gribble, F. M., Reimann, F., & Skibicka, K. P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119034 · Cited by 168
α1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol
Walker, B. M., Rasmussen, D. D., Raskind, M. A., & Koob, G. F. (2008) · Alcohol · doi:10.1016/j.alcohol.2007.12.002 · Cited by 167
Potent Regulation of Midbrain Dopamine Neurons by the Bed Nucleus of the Stria Terminalis
Georges, F., & Aston-Jones, G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-j0003.2001 · Cited by 163
“This connection and other results indicating a role of the vBNST in opiate abuse (Delfs et al., 2000; Walker et al., 2000) indicate that functional interactions may exist between the vBNST and VTA DA neurons; however, such interactions have not been reported previously.”
BackgroundResultInfluentialSelf-citationSerafini, G., Adavastro, G., Canepa, G., De Berardis, D., Valchera, A., Pompili, M., Nasrallah, H., & Amore, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082410 · Cited by 162
“It has been reported that MOR activation in the dorsal raphe nucleus (DRN) and ventral tegmental area (VTA) by local GABAergic interneurons disinhibits both 5-HT and DA neurons, but inhibits noradrenergic neurons [26,30,31].”
BackgroundSkelly, M. J., Chappell, A. E., Carter, E., & Weiner, J. L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.025 · Cited by 161
Neurobiology of dysregulated motivational systems in drug addiction
Edwards, S., & Koob, G. F. (2010) · Future Neurology · doi:10.2217/fnl.10.14 · Cited by 157
“By contrast, the projections from the brainstem via the ventral bundle to the extended amygdala mediate behavioral responses to stressors [72,73].”
BackgroundAutonomic brainstem nuclei are linked to the hippocampus
Castle, M., Comoli, E., & Loewy, A. D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.031 · Cited by 157
Wee, S., Mandyam, C. D., Lekić, D., & Koob, G. F. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.08.003 · Cited by 152
Orexigenic Peptides and Alcohol Intake: Differential Effects of Orexin, Galanin, and Ghrelin
Schneider, E. R., Rada, P., Darby, R. D., Leibowitz, S. F., & Hoebel, B. G. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00510.x · Cited by 148
Dumont, É. C., Mark, G. P., Mader, S. L., & Williams, J. T. (2005) · Nature Neuroscience · doi:10.1038/nn1414 · Cited by 144
From Malthus to motive: How the HPA axis engineers the phenotype, yoking needs to wants
Pecoraro, N. C., Dallman, M. F., Warne, J. P., Ginsberg, A. B., Laugero, K. D., la Fleur, S. E., Houshyar, H., Gómez-Oliver, F., Bhargava, A., & Akana, S. F. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.004 · Cited by 144
Neuroanatomical characterization of endogenous opioids in the bed nucleus of the stria terminalis
Poulin, J.-F., Arbour, D., Laforest, S., & Drolet, G. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.021 · Cited by 142
McNally, G. P., & Akil, H. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00105-7 · Cited by 141
“…and Grigoriadis, 1995; Mansour et al., 1995), and lesions or microinjections of various receptor antagonists into these regions reduce many of the consequences of morphine withdrawal (e.g., Calvino et al., 1979; Delfs et al., 2000; Heinrichs et al., 1995; Koob et al., 1992; Maldonado et al., 1992).”
BackgroundAlcohol Use Disorder: Neurobiology and Therapeutics
Yang, W., Singla, R., Maheshwari, O., Fontaine, C. J., & Gil‐Mohapel, J. (2022) · Biomedicines · doi:10.3390/biomedicines10051192 · Cited by 140
Stinus, L., Cador, M., Zorrilla, E. P., & Koob, G. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300487 · Cited by 139
“Particularly intriguing are recent studies demonstrating a role for norepinephrine in the bed nucleus of the stria terminalis in the conditioned place aversions associated with opiate withdrawal (Delfs et al, 2000).”
BackgroundMoberg, C. A., & Curtin, J. J. (2009) · Journal of Abnormal Psychology · doi:10.1037/a0015636 · Cited by 138
Individual differences in the neuropsychopathology of addiction
George, O., & Koob, G. F. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/gkoob · Cited by 138
Dumont, É. C., & Williams, J. T. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0425-04.2004 · Cited by 138
Gracy, K. N., Dankiewicz, L. A., & Koob, G. F. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00186-x · Cited by 135
Modulation of Anxiety-Like Behavior and Morphine Dependence in CREB-Deficient Mice
Valverde, O., Mantamadiotis, T., Torrecilla, M., Ugedo, L., Pineda, J., Bleckmann, S. C., Gass, P., Kretz, O., Mitchell, J., Schütz, G., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300416 · Cited by 133
Stamatakis, A. M., Sparta, D. R., Jennings, J. H., McElligott, Z. A., Decot, H., & Stuber, G. D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.046 · Cited by 132
Mejías-Aponte, C. A., Drouin, C., & Aston-Jones, G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4632-08.2009 · Cited by 132
Self-citationNazzi, T., Floccia, C., Moquet, B., & Butler, J. (2008) · Journal of Experimental Child Psychology · doi:10.1016/j.jecp.2008.05.003 · Cited by 131
Hammack, S. E., Richey, K. J., Watkins, L. R., & Maier, S. F. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.2.443 · Cited by 130
Akbarian, S., Rios, M., Liu, R.-J., Gold, S. J., Fong, H.-F., Zeiler, S., Coppola, V., Tessarollo, L., Jones, K. R., Nestler, E. J., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-04153.2002 · Cited by 130
Role of Noradrenergic Signaling by the Nucleus Tractus Solitarius in Mediating Opiate Reward
Olson, V. G., Heusner, C. L., Bland, R. J., During, M. J., Weinshenker, D., & Palmiter, R. D. (2006) · Science · doi:10.1126/science.1119311 · Cited by 126
Kash, T. L., Nobis, W. P., Matthews, R. T., & Winder, D. G. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4715-08.2008 · Cited by 125
Mena, J. D., Sadeghian, K., & Baldo, B. A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2050-10.2011 · Cited by 125
Norepinephrine Modulates Glutamatergic Transmission in the Bed Nucleus of the Stria Terminalis
Egli, R. E., Kash, T. L., Choo, K. S., Savchenko, V. L., Matthews, R. T., Blakely, R., & Winder, D. G. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300639 · Cited by 125
Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action
Kim, K.-S., Lee, K.-W., Lee, K.-W., Im, J.-Y., Yoo, J. Y., Kim, S.-W., Lee, J.-K., Nestler, E. J., & Han, P.-L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508812103 · Cited by 123
Allostatic mechanisms of opioid tolerance beyond desensitization and downregulation
Cahill, C. M., Walwyn, W., Taylor, A. M. W., Pradhan, A. A. A., & Evans, C. J. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.08.002 · Cited by 122
Ventura, R., Alcaro, A., & Puglisi-Allegra, S. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhi066 · Cited by 120
Fendt, M., Siegl, S., & Steiniger-Brach, B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1028-05.2005 · Cited by 118
A Specific Limbic Circuit Underlies Opiate Withdrawal Memories
Frenois, F., Stinus, L., Di Blasi, F., Cador, M., & Le Moine, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3090-04.2005 · Cited by 117
Metadata
- Authors
- Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G.
- Affiliations
- Philadelphia VA Medical Center (US)
- University of Pennsylvania (US)
- Venue
- Nature
- Published
- 2000-01
- Volume
- 403
- Issue
- 6768
- Pages
- 430-434
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1659240124
- Semantic Scholar
- 973cb279566f11006ae21f697af863157189bf18
- Cited by
- 462
- References
- 31
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 3 · 2023: 16 · 2022: 12 · 2021: 10 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 11 · 2016: 12 · 2015: 18 · 2014: 8 · 2013: 18 · 2012: 24
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- norepinephrine, opioid withdrawal, conditioned place aversion, bed nucleus of the stria terminalis, caudal medulla, noradrenergic projections, alpha-2 adrenergic agonists, locus coeruleus, ventral forebrain, aversive conditioning
- MeSH terms
- Adrenergic alpha-Agonists, Adrenergic beta-Antagonists, Amygdala, Animals, Clonidine, Male, Narcotics, Neurons, Afferent, Norepinephrine, Propanolamines, Propranolol, Substance Withdrawal Syndrome, Tyrosine 3-Monooxygenase, Betaxolol, Prosencephalon, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.